Pharma Journalist - Page 690 of 834 -

Axcynsis Receives FDA Clearance for IND of AT03-65, CLDN6-Targeting ADC

FDA Approves Lilly’s Omvoh for Crohn’s Disease, Expanding IBD Treatment Options

AbbVie and Simcere Zaiming Partner to Develop Trispecific Antibody for Multiple Myeloma

BioProcess International European Summit: Connecting Science, Technology and Business to Optimise Bioprocessing

AstraZeneca asserts the availability of FLUMIST QUADRIVALENT Vaccine in U.S

NaviGate Cardiac Structures declares GATE bioprosthesis to treat tricuspid regurgitation

Clovis Oncology sought positive vote from CHMP for Rucaparib tablets

Merck forays into acquiring Viralytics augmenting Immuno-Oncology Pipeline

Biologics assures availability of ERLEADA treatment for Non-Metastatic, Castration-Resistant Prostate Cancer

Vertex commences Phase 3 Study of VX-659 for CF

FDA monitors destruction and recall of kratom products

Chiron Recovery executed a MAT program for opioid addiction